Physician profile
David M Schall
NPI 1932170057
$23,000.12
in general payments reported to CMS, 2019-2025
19 companies · $2,993 in 2025
The $2,993 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $901 · 2021: $1,296 · 2022: $9,209 · 2023: $5,836 · 2024: $1,900 · 2025: $2,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,024 · Travel and Lodging: $4,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,023.78 |
| Travel and Lodging | $4,704.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,804.05 | 2019-2025 | Mako, Triathlon, Tritanium |
| Orthalign INC | $3,253.76 | 2022-2025 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $3,223.19 | 2019-2025 | Oxford, Rosa, Echo Press-Fit Hip System |
| Depuy Synthes Sales INC. | $3,183.65 | 2019-2025 | Attune, Actis, Va-Lcp |
| Medical Device Business Services, INC. | $2,744.15 | 2022-2025 | Velys |
| Medtronic, INC. | $652.60 | 2022-2024 | Aquamantys(Tm) |
| Sanara Medtech INC. | $399.33 | 2024-2025 | Celleraterx, Celleraterx, Biasurge |
| Smith+Nephew, INC. | $365.98 | 2023-2024 | Pico, Legion, Engage Partial Knee System |
| Sioux Surgical INC | $344.76 | 2019-2025 | |
| Arthrex, INC. | $243.42 | 2022-2025 | |
| Heron Therapeutics, INC. | $206.15 | 2022-2024 | Zynrelef |
| Davol INC. | $132.50 | 2025 | Arista |
| Linvatec Corporation | $100.67 | 2025 | Biobrace 23mm |
| Innovation Technologies INC | $100.52 | 2025 | Irrisept |
| Kci USA, INC. | $74.42 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $71.95 | 2023 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $47.44 | 2023 | Exparel, Iovera |
| Rsw Medical Company, INC. | $35.05 | 2019 | |
| Organogenesis INC. | $16.53 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.